News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK) and Johnson & Johnson (JNJ) Back StartX


9/13/2013 8:02:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Two Big Pharma companies, Merck (NYSE:MRK) and Johnson & Johnson (NYSE:JNJ), are the latest partners to sign on to support healthcare startups that come out of Stanford University. StartX, the accelerator that spun out of Stanford in 2009, said Thursday at its demo day in Palo Alto (which I watched via live stream) that both companies will provide financial support to StartX Med, the leg of the accelerator devoted to health and health IT ventures. Merck will provide strategic guidance and end-user feedback to digital health, data and analytics companies in the accelerator, while Johnson & Johnson will work with the medical device and biopharmaceutical companies.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES